Nanopath, a molecular diagnostics start-up, has been chosen as the primary winner of the just lately launched INTEGRA helps start-ups competitors, receiving 30 EVOLVE handbook pipettes to assist the corporate additional develop its novel expertise and translate the tactic to the clinic. Nanopath’s imaginative and prescient is to disrupt conventional testing methodologies for girls in outpatient settings, using a novel diagnostics platform that avoids the amplification steps utilized in PCR, enabling speedy testing nearer to the purpose of care.
“Nanopath is a small firm, and our group brings multifaceted experience that spans assay growth and engineering. With all our lab technicians utilizing the identical pipettes for every workflow, we are able to guarantee consistency between customers and construct a stable basis of information that we are able to belief. Profitable the pipettes will undoubtedly positively impression Nanopath’s journey in a big method.”
Dr Amogha Tadimety, Co-Founder and CEO at Nanopath
The Nanopath group was already utilizing the ASSIST PLUS pipetting robotic and the VOYAGER adjustable tip spacing pipette to automate the liquid dealing with workflows that underpin its expertise, and this optimistic expertise inspired the group to use for the INTEGRA prize: “Beginning with these merchandise made a tangible distinction to a small firm like ours. We had been capable of considerably improve our throughput at an early stage, quadrupling the variety of affected person samples we may run in a day, whereas offering superior accuracy. Constructing a relationship with a supportive provider like INTEGRA is invaluable to start-ups like us, and we might extremely advocate different modern disruptors within the biotechnology sector to use to this program.”
Go to the INTEGRA Biosciences web site to be taught extra.
